119 studies found for:    hemophilia | Open Studies
Show Display Options
Rank Status Study
21 Unknown  Turkish Acquired Haemophilia Registry
Condition: Acquired Haemophilia
Intervention: Drug: rFVIIIa, aPCC, FVIII, DDAVP, Azathioprine, Rituximab, Cyclosporin
22 Recruiting Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B
Condition: Hemophilia B
Intervention: Biological: AskBio009
23 Recruiting An Open-label Extension Study of an Investigational Drug, ALN-AT3SC, in Patients With Moderate or Severe Hemophilia A or B
Conditions: Hemophilia A;   Hemophilia B
Intervention: Drug: ALN-AT3SC
24 Not yet recruiting Individualized Prophylaxis for Severe Hemophilia A Children
Condition: Hemophilia
Intervention: Other: according to the efficacy of AJBRs
25 Recruiting National Study of a Pharmacokinetic-Focused Educational Package for Patients With Severe Haemophilia A
Condition: Hemophilia A
Intervention: Behavioral: Educational Package
26 Unknown  Allogenic Bone Marrow Derived Mesenchymal Stem Cell Therapy in Cases of Hemophilia
Condition: Hemophilia
Interventions: Biological: Cellular therapy;   Biological: cellular therapy
27 Recruiting Safety and Dose Finding Study of DTX101 (AAVrh10FIX) in Adults With Moderate/Severe to Severe Hemophilia B
Condition: Hemophilia B
Intervention: Genetic: AAVrh10FIX
28 Recruiting Multidisciplinary Evaluation of Patients With Hemophilia
Condition: Haemophilia
Intervention:
29 Recruiting A Phase III Study on the Safety, Pharmacokinetics and Efficacy of Coagulation Factor VIIa (Recombinant) in Congenital Hemophilia A or B Patients From ≥6 Months Old to <12 Years Old With Inhibitors to Factor VIII or IX
Conditions: Hemophilia A With Inhibitors;   Hemophilia B With Inhibitors
Intervention: Biological: Coagulation FVIIa (Recombinant)
30 Recruiting Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A
Condition: Severe Hemophilia A
Intervention: Drug: Alphanate SD/HT
31 Recruiting Weight-based Dosing in Hemophilia A
Condition: Hemophilia
Intervention: Drug: rFVIII
32 Not yet recruiting Biomechanical Determinants and Patterns Associated to the Pathophysiological Cascade of Ankle Arthropathy in Children With Haemophilia: Non-invasive In-vivo Measurement of Foot Joints in Children With Haemophilia During Gait.
Conditions: Haemophilia;   Arthropathy
Intervention: Other: Gait analysis
33 Recruiting ATHN 2: Factor Switching Study
Condition: Hemophilia
Interventions: Biological: Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013;   Biological: Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013
34 Recruiting Validation of Questionnaires HAL and HEP
Condition: Haemophilia
Intervention:
35 Unknown  Study of Recombinant Factor IX Product, IB1001, in Previously Treated Subjects With Hemophilia B
Condition: Hemophilia B
Intervention: Biological: IB1001
36 Recruiting Outcome of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab (CREHA Study)
Condition: Acquired Haemophilia
Interventions: Drug: Steroid + cyclophosphamide;   Drug: Steroid + rituximab
37 Recruiting Safety and Efficacy of BAY94-9027 in Previously Treated Male Children With Haemophilia A
Condition: Hemophilia A
Intervention: Biological: BAY94-9027
38 Recruiting An Open Label Study to Determine the Safety and Efficacy of Replacement Factor VIII Protein (Known as rFVIIIFc) in Untreated Males With Severe Hemophilia A
Condition: Hemophilia A
Intervention: Biological: rFVIIIFc
39 Not yet recruiting Prospective Biomarkers of Bone Metabolism in Hemophilia A
Conditions: Hemophilia;   Bone Disease
Intervention: Drug: Advate
40 Unknown  Personalized Prediction of Tolerance and Immunogenicity in Hemophilia
Condition: Hemophilia A
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years